tiprankstipranks
Trending News
More News >
Daito Pharmaceutical Co., Ltd. (JP:4577)
:4577
Japanese Market
Advertisement

Daito Pharmaceutical Co., Ltd. (4577) Stock Statistics & Valuation Metrics

Compare
0 Followers

Total Valuation

Daito Pharmaceutical Co., Ltd. has a market cap or net worth of ¥36.89B. The enterprise value is ¥39.50B.
Market Cap¥36.89B
Enterprise Value¥39.50B

Share Statistics

Daito Pharmaceutical Co., Ltd. has 30,096,880 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding30,096,880
Owned by Insiders
Owned by Institutions

Financial Efficiency

Daito Pharmaceutical Co., Ltd.’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)
Return on Assets (ROA)
Return on Invested Capital (ROIC)
Return on Capital Employed (ROCE)
Revenue Per Employee47.33M
Profits Per Employee1.78M
Employee Count1,070
Asset Turnover
Inventory Turnover

Valuation Ratios

The current PE Ratio of Daito Pharmaceutical Co., Ltd. is 19.5. Daito Pharmaceutical Co., Ltd.’s PEG ratio is ―.
PE Ratio19.5
PS Ratio
PB Ratio
Price to Fair Value
Price to FCF
Price to Operating Cash Flow10.29
PEG Ratio

Income Statement

In the last 12 months, Daito Pharmaceutical Co., Ltd. had revenue of 50.64B and earned 1.91B in profits. Earnings per share was 62.72.
Revenue50.64B
Gross Profit8.64B
Operating Income2.62B
Pretax Income2.96B
Net Income1.91B
EBITDA7.41B
Earnings Per Share (EPS)62.72

Cash Flow

In the last 12 months, operating cash flow was 1.84B and capital expenditures -4.89B, giving a free cash flow of -3.05B billion.
Operating Cash Flow1.84B
Free Cash Flow-3.05B
Free Cash Flow per Share-101.27

Dividends & Yields

Daito Pharmaceutical Co., Ltd. pays an annual dividend of ¥17.5, resulting in a dividend yield of 4.28%
Dividend Per Share¥17.5
Dividend Yield4.28%
Payout Ratio83.68%
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.31
52-Week Price Change10.43%
50-Day Moving Average1.15K
200-Day Moving Average1.05K
Relative Strength Index (RSI)55.25
Average Volume (3m)61.53K

Important Dates

Daito Pharmaceutical Co., Ltd. upcoming earnings date is Oct 9, 2025, TBA (Confirmed).
Last Earnings DateJul 11, 2025
Next Earnings DateOct 9, 2025
Ex-Dividend DateMay 29, 2025

Financial Position

Daito Pharmaceutical Co., Ltd. as a current ratio of ―, with Debt / Equity ratio of 20.36%
Current Ratio
Quick Ratio
Debt to Market Cap
Net Debt to EBITDA
Interest Coverage Ratio

Taxes

In the past 12 months, Daito Pharmaceutical Co., Ltd. has paid 1.19B in taxes.
Income Tax1.19B
Effective Tax Rate

Enterprise Valuation

Daito Pharmaceutical Co., Ltd. EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales
EV to EBITDA
EV to Free Cash Flow
EV to Operating Cash Flow

Balance Sheet

Daito Pharmaceutical Co., Ltd. has ¥2.38B in cash and marketable securities with ¥10.49B in debt, giving a net cash position of ¥8.11B billion.
Cash & Marketable Securities¥2.38B
Total Debt¥10.49B
Net Cash¥8.11B
Net Cash Per Share¥269.60
Tangible Book Value Per Share

Margins

Gross margin is 18.26%, with operating margin of ―, and net profit margin of ―.
Gross Margin18.26%
Operating Margin
Pretax Margin
Net Profit Margin
EBITDA Margin
EBIT Margin

Analyst Forecast

The average price target for Daito Pharmaceutical Co., Ltd. is ¥1,370.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target¥1,370.00
Price Target Upside11.75% Upside
Analyst ConsensusModerate Buy
Analyst Count0
Revenue Growth Forecast7.99%
EPS Growth Forecast-51.78%

Scores

Smart ScoreN/A
AI Score70
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis